Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 30, 2022
Source ID
10.1038/s43018-022-00489-5

Entities

People

  • Andrea Califano
  • Anthony High
  • Cody Chiuzan
  • Dawn L. Hershman
  • Erin Honan
  • Haiyan Tan
  • Jiyang Yu
  • Jose Silva
  • Junmin Peng
  • Katherine D. Crew
  • Kathleen Fenn
  • Kevin Kalinsky
  • Maika Onishi
  • Mariano J. Alvarez
  • Matthew Maurer
  • Meghna S. Trivedi
  • Melissa Accordino
  • Min Yang
  • Partha Mukhopadhyay
  • Pei Ling Chia
  • Qingfei Pan
  • Ruby Wu
  • Sean H Kelly
  • Simon C Jones
  • Tizita Z. Zeleke
  • Yuxin Li

Organizations

  • American Lebanese Syrian Associated Charities
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • United States Department of Defense